Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F P Kroon

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Clinical and Diagnostic Laboratory Immunology|May 4, 1999
Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoidF P Kroon, M J van Tol, C M Jol-van der Zijde, et al.
AIDS (London, England)|December 24, 1998
Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapyF P Kroon, G F Rimmelzwaan, M T Roos, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1997
Absence of Epstein-Barr virus (EBV) in a gastrointestinal stromal cell tumour (GIST) in an adult human immunodeficiency virus-seropositive patient with past EBV infectionF J Kubben, F P Kroon, P C Hogendoorn, et al.
AIDS (London, England)|December 28, 2000
No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patientsE F Schippers, P W Hugen, J den Hartigh, et al.
The Journal of Infectious Diseases|August 7, 1999
Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected personsM F Geertsma, A van Wengen-Stevenhagen, E M van Dam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1996
Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virusA M van Elsacker-Neile, F P Kroon, M E van der Ende, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothersI J M Snijdewind, C Smit, M Schutten, et al.
Annals of the Rheumatic Diseases|September 21, 2007
Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximabL B S Gelinck, Y K O Teng, G F Rimmelzwaan, et al.
AIDS (London, England)|November 14, 1998
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavirD M Burger, P W Hugen, F P Kroon, et al.
Pharmacy World & Science : PWS|July 26, 2002
Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfastP W H Hugen, D M Burger, P P Koopmans, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical and Diagnostic Laboratory Immunology|May 4, 1999
Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoidF P Kroon, M J van Tol, C M Jol-van der Zijde, et al.
AIDS (London, England)|December 24, 1998
Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapyF P Kroon, G F Rimmelzwaan, M T Roos, et al.
European Journal of Gastroenterology & Hepatology|July 1, 1997
Absence of Epstein-Barr virus (EBV) in a gastrointestinal stromal cell tumour (GIST) in an adult human immunodeficiency virus-seropositive patient with past EBV infectionF J Kubben, F P Kroon, P C Hogendoorn, et al.
AIDS (London, England)|December 28, 2000
No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patientsE F Schippers, P W Hugen, J den Hartigh, et al.
The Journal of Infectious Diseases|August 7, 1999
Decreased expression of zeta molecules by T lymphocytes is correlated with disease progression in human immunodeficiency virus-infected personsM F Geertsma, A van Wengen-Stevenhagen, E M van Dam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1996
Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virusA M van Elsacker-Neile, F P Kroon, M E van der Ende, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 14, 2015
Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected mothersI J M Snijdewind, C Smit, M Schutten, et al.
Annals of the Rheumatic Diseases|September 21, 2007
Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximabL B S Gelinck, Y K O Teng, G F Rimmelzwaan, et al.
AIDS (London, England)|November 14, 1998
Pharmacokinetic interaction between the proton pump inhibitor omeprazole and the HIV protease inhibitor indinavirD M Burger, P W Hugen, F P Kroon, et al.
Pharmacy World & Science : PWS|July 26, 2002
Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfastP W H Hugen, D M Burger, P P Koopmans, et al.
Pageof 6